title: Prostate cancer research and the National Cancer Institute.
abstract: The National Cancer Institute (NCI) is the largest funder of prostate cancer research in the United States and indeed the world. It is sponsoring a number of studies to answer the significant questions pertinent to prostate cancer and pertinent to black men. These include studies of epidemiology; cancer prevention, screening, and control; clinical treatment; and basic science. In addition, the NCI is charged with dissemination of research findings to physicians and the lay public. The following is a description of the NCI prostate cancer research portfolio including the scientific questions being addressed and how are they being addressed.
authors.affiliation: Office of Special Populations Research, National Cancer Institute, Bethesda, MD 20892, USA.
authors.forename: O W
authors.initials: OW
authors.lastname: Brawley
authors.forename: N
authors.initials: N
authors.lastname: Figueroa-Valles
mesh_terms: D001741:Black or African American; D002986:Clinical Trials as Topic; D006801:Humans; D007255:Information Services; D008297:Male; D009316:National Institutes of Health (U.S.) / Q000458:organization & administration*; D011471:Prostatic Neoplasms / Q000453:epidemiology* / Q000208:ethnology / Q000209:etiology; D012109:Research Support as Topic; D018426:SEER Program; D014481:United States / Q000453:epidemiology